IndraLab

Statements


| 1

reach
"Although lapatinib alone appeared to decrease both total STAT1 and pSTAT1-S727 immunolabeling, the ratio of pSTAT1-S727 to tSTAT1 was not significantly different between lapatinib and control arms."